LONDON, December 16 /PRNewswire/ -- CMPMedica, a global healthcare information provider that is a division of United Business Media Limited, has signed a worldwide agreement to supply iSOFT, one of the world's largest providers of healthcare IT solutions, with comprehensive evidence-based drug information. CMPMedica's information solution will power iSOFT's fully integrated suite of decision support tools. These tools enable healthcare professionals to make better informed decisions at the point of care and thus improve patient outcomes.

CMPMedica is one of the world's leading providers of drug information content to healthcare professionals (http://www.cmpmedica.com), with trusted brands such as Vidal (http://www.vidal.fr), MIMS (http://www.mims.com), Glebe Liste Pharmindex (http://www.gelbe-liste.de) and Vademecum (http://www.vademecum.es). CMPMedica has a strong local presence in 24 countries across Europe and Asia/Pacific. CMPMedica's global expertise and strong local presence enables it to deliver unique drug information solutions. CMPMedica's strategy is to work directly with healthcare providers and with the leading healthcare IT suppliers to make the best evidence-based decision support tools available at the point of care. CMPMedica is unique in its ability to combine internationally referenced alert tools with comprehensive local product information, all delivered to IT partners through a common interface.

CMPMedica has supplied iSOFT with drug information systems for over 40 years and this extended relationship is a testament to how well the two companies have worked together to develop their respective businesses in Australia and Asia. Both companies are looking to expand their relationship into new territories around the world as demand for evidence-based decision support tools continues to grow.

Healthcare providers increasingly recognise the need for comprehensive, up to date information to support the treatment decisions of their healthcare professionals.

Henry Elkington, CEO of CMPMedica said: The award of this contract demonstrates that we are addressing the needs of one of the most dynamic multi-national healthcare solution providers. By providing trusted local data with best-in-class decision support tools we are enabling solutions that will be recognised and welcomed by clinicians. In addition, by delivering data through a common interface we can speed up and simplify deployment for the solution provider.

We are delighted to be able to build on our existing relationship with iSOFT and look forward to supporting the growth and development of their business around the world.

Dr Michael Dahlweid, iSOFT's Chief Medical Officer said: The agreement with CMPMedica will provide improved and real-time access to CMPMedica's sophisticated knowledge bases. When interacting with iSOFT products, these decision support tools will provide the capacity to alert clinicians to interactions between medicines, food, health conditions and patient allergies and more, making patient safety the priority in a world of increasing drug complexity.

This new service will strengthen the quality of the drug content available within iSOFT products giving our customers ready access to the very latest drug and allergy information ensuring that prescribing clinicians have up-to-date and fully integrated drug information to enhance patient treatment and safety.

Notes to Editors

1. About CMPMedica

CMPMedica provides information and education to healthcare professionals and patients around the world. It has a unique portfolio of professional media products including newspapers, magazines, drug directories, electronic databases, websites and events.

For more information, go to http://www.cmpmedica.com.

Contacts: Media: Andrew Frangleton, Healthcare Informatics Director, Email afrangleton@cmpmedica.com, Direct telephone, +44-207-921-8328; Peter Bancroft, Director of Communications, E-mail communications@ubmgroup.biz, Direct telephone, +44-207-921-5961